Chemical Compound

3H-21,18-Nitrilo-1H,22H-pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone, 8,9,14,15,24,25-hexahydro-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-, (3R,4R,5E,10E,12E,14S)-; Mikamycin A (6CI,8CI); Ostreogrycin A (7CI); Virginiamycin M1; (3R,4R,5E,10E,12E,14S)-8,9,14,15,24,25-Hexahydro-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-3H-21,18-nitrilo-1H,22H-pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone; Antibiotic PA 114A; Antibiotic PA 114A1; Factor M; Factor M (antibiotic); NSC 244426; NSC 87432; PA 114A; Pristinamycin II; Pristinamycin IIA; RP 12536; Staphylomycin M1; Streptogramin A; Vernamycin A; [3R-(3R*,4R*,5E,10E,12E,14S*)]-8,9,14,15,24,25-Hexahydro-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-3H-21,18-nitrilo-1H,22H-pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone

CAS Registry Number 21411-53-0
返回搜索 申请报价
3H-21,18-Nitrilo-1H,22H-pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone, 8,9,14,15,24,25-hexahydro-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-, (3R,4R,5E,10E,12E,14S)-; Mikamycin A (6CI,8CI); Ostreogrycin A (7CI); Virginiamycin M1; (3R,4R,5E,10E,12E,14S)-8,9,14,15,24,25-Hexahydro-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-3H-21,18-nitrilo-1H,22H-pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone; Antibiotic PA 114A; Antibiotic PA 114A1; Factor M; Factor M (antibiotic); NSC 244426; NSC 87432; PA 114A; Pristinamycin II; Pristinamycin IIA; RP 12536; Staphylomycin M1; Streptogramin A; Vernamycin A; [3R-(3R*,4R*,5E,10E,12E,14S*)]-8,9,14,15,24,25-Hexahydro-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-3H-21,18-nitrilo-1H,22H-pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone 结构式
Primary record

3H-21,18-Nitrilo-1H,22H-pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone, 8,9,14,15,24,25-hexahydro-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-, (3R,4R,5E,10E,12E,14S)-; Mikamycin A (6CI,8CI); Ostreogrycin A (7CI); Virginiamycin M1; (3R,4R,5E,10E,12E,14S)-8,9,14,15,24,25-Hexahydro-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-3H-21,18-nitrilo-1H,22H-pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone; Antibiotic PA 114A; Antibiotic PA 114A1; Factor M; Factor M (antibiotic); NSC 244426; NSC 87432; PA 114A; Pristinamycin II; Pristinamycin IIA; RP 12536; Staphylomycin M1; Streptogramin A; Vernamycin A; [3R-(3R*,4R*,5E,10E,12E,14S*)]-8,9,14,15,24,25-Hexahydro-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-3H-21,18-nitrilo-1H,22H-pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone

库存
1,109 克
纯度
98.2 %
CAS
21411-53-0

化合物标识与属性

CAS
21411-53-0
PubChem CID
5459319
SMILES
C[C@@H]1/C=C/C(=O)NC/C=C/C(=C/[C@H](CC(=O)CC2=NC(=CO2)C(=O)N3CCC=C3C(=O)O[C@@H]1C(C)C)O)/C
Canonical SMILES
CC1=C\[C@@H](O)CC(=O)Cc2nc(co2)C(=O)N2CCC=C2C(=O)O[C@H](C(C)C)[C@H](C)/C=C/C(=O)NC\C=C\1

名称与同义词

  • virginiamycin m1
  • Streptogramin A
  • Ostreogrycin a
  • Mikamycin A
  • Pristinamycin IIA
  • Staphylomycin M1
  • VERNAMYCIN A
  • Pristinamycin
  • Staphylomycin
  • Virginiamycin Factor M1
  • Pyostacine
  • Staphylomycin M
  • Antibiotic pa 114a
  • Factor M
  • Antibiotic PA 114A1
  • Virginiamycin IIB
  • Virginiamycin M1-dx
  • Virginiamycin M1-d2
  • VIRGINIAMYCINM1
  • 8W4UOL59AZ
  • RefChem:185930
  • MIKAMYCIN A [MI]
  • Vernamycin A & B mixture
  • Virginiamycin M1 (~90%)
  • UNII-8W4UOL59AZ
  • PA-114A
  • Virginiamycin M1 (90%)
  • CHEBI:9997
  • STREPTOGRAMIN A [MI]
  • orb746832
  • DAIKHDNSXMZDCU-FQTGFAPKSA-N
  • NSC-87432
  • PRISTINAMYCIN IIA [MI]
  • VIRGINIAMYCIN M1 [MI]
  • orb1741534
  • orb3024943
  • 21411-53-0
  • CHEMBL1236670
  • NSC-244426
  • NSC87434
  • GTPL12933
  • DTXSID30873800
  • PA 114A
  • C28H35N3O7
  • DTXCID401012018
  • RP-12536
  • NSC 244426
  • HY-N6686
  • NSC87432
  • EINECS 244-376-6
  • MFCD00869411
  • NSC 87432
  • NSC-87434
  • NSC244426
  • Vernamycin A & vernamycin B (1:1)
  • DB01669
  • EBC-616376
  • Vernamycin A, mixture with vernamycin B
  • FV159221
  • RP 12536
  • VERNAMYCIN A & B MIXTURE (1:1)
  • LS-187695
  • CS-0019826
  • NS00011661
  • C11299
  • E80259
  • Virginiamycin M1 (~90%) (200 ug/mL in Methanol)
  • Virginiamycin M1 (200 ug/mL in Methanol) (~90%)
  • 8,9,14,15,24,25-Hexahydro-14-hydroxy-3-isopropyl-4,12-dimethyl-3H-21,18-nitrilo-1H,22H-pyrrolo(2,1-c)(1,8,4,19)dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone
  • (10R,11R,12E,17E,19E,21S)-21-Hydroxy-10-isopropyl-11,19-dimethyl-9,26-dioxa-3,15,28-triazatricyclo[23.2.1.03,7]octacosa-1(27),6,12,17,19,25(28)-hexaene-2,8,14,23-tetrone
  • (10R,11R,12E,17E,19E,21S)-21-hydroxy-11,19-dimethyl-10-(propan-2-yl)-9,26-dioxa-3,15,28-triazatricyclo[23.2.1.0,3,7]octacosa-1(27),6,12,17,19,25(28)-hexaene-2,8,14,23-tetrone
  • (10R,11R,12E,17E,19E,21S)-21-hydroxy-11,19-dimethyl-10-propan-2-yl-9,26-dioxa-3,15,28-triazatricyclo(23.2.1.03,7)octacosa-1(27),6,12,17,19,25(28)-hexaene-2,8,14,23-tetrone
  • (10R,11R,12E,17E,19E,21S)-21-hydroxy-11,19-dimethyl-10-propan-2-yl-9,26-dioxa-3,15,28-triazatricyclo[23.2.1.03,7]octacosa-1(27),6,12,17,19,25(28)-hexaene-2,8,14,23-tetrone
  • (3R,4R,5E,10E,12E,14S)-14-hydroxy-3-isopropyl-4,12-dimethyl-8,9,14,15,24,25-hexahydro-1H,3H,22H-21,18-(azeno)pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone
  • (3R,4R,5E,10E,12E,14S)-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-8,9,14,15,24,25-hexahydro-1H,3H,22H-21,18-(azeno)pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone
  • (3R,4R,5E,10E,12E,14S)-8,9,14,15,24,25-Hexahydro-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-3H-21,18-nitrilo-1H,22H-pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone
  • (3R-(3R*,4R*,5E,10E,12E,14S*))-8,9,14,15,24,25-HEXAHYDRO-14-HYDROXY-4,12-DIMETHYL-3-(1-METHYLETHYL)-3H-21,18-NITRILO-1H,22H-PYRROLO(2,1-C)(1,8,4,19)DIOXADIAZACYCLOTETRACOSINE-1,7,16,22(4H,17H)-TETRONE
  • 244-376-6
  • 3H-21,18-NITRILO-1H,22H-PYRROLO(2,1-C)(1,8,4,19)DIOXADIAZACYCLOTETRACOSINE-1,7,16,22(4H,17H)-TETRONE, 8,9,14,15,24,25-HEXAHYDRO-14-HYDROXY-4,12-DIMETHYL-3-(1-METHYLETHYL)-, (3R,4R,5E,10E,12E,14S)-
  • 3H-21,18-Nitrilo-1H,22H-pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone, 8,9,14,15,24,25-hexahydro-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-, (3R,4R,5E,10E,12E,14S)-; Mikamycin A (6CI,8CI); Ostreogrycin A (7CI); Virginiamycin M1; (3R,4R,5E,10E,12E,14S)-8,9,14,15,24,25-Hexahydro-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-3H-21,18-nitrilo-1H,22H-pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone; Antibiotic PA 114A; Antibiotic PA 114A1; Factor M; Factor M (antibiotic); NSC 244426; NSC 87432; PA 114A; Pristinamycin II; Pristinamycin IIA; RP 12536; Staphylomycin M1; Streptogramin A; Vernamycin A; [3R-(3R*,4R*,5E,10E,12E,14S*)]-8,9,14,15,24,25-Hexahydro-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-3H-21,18-nitrilo-1H,22H-pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone
  • 8,9,14,15,24,25-Hexahydro-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-3H-21,18-nitrilo-1H,22H-pyrrolo(2,1-c)(1,8,4,19)dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone
  • VIR